Liverpool Health Economics


The team at LHE have successfully conducted research in a wide range of therapeutic areas. A number of projects undertaken have enabled LHE to significantly impact and influence national and international health policy by optimising NHS decision-making on drug adoption and other clinical interventions, as well as disseminating HTA expertise and application around the globe. The scope of projects are both geographical and organisational, spanning the UK NHS, European, African and Asian healthcare systems, moreover, the pharmaceutical industry.

Group interests

  • Economic evaluation in clinical trials
  • Economic modelling
  • End of life care
  • Health economics to assist with local decision making
  • Health economics in resource poor countries
  • Health services research
  • Pharmaceutical pricing and reimbursement
  • Statistical analysis of data sets
  • Systematic reviews

Recent grants



2013 - 2018

De-Escalatation and Stopping Treatment with Imatinib, Nilotinib or sprYcel in CML (the DESTINY trial)


Economic evaluation of contact x-ray radiotherapy for the treatment of patient with early stage colorectal cancer (Papillon study).

2014 - 2016

Cattell Warren versus Blumgart techniques of pancreatico -jejunostomy following pancreato-duodenectomy - a double blinded multi-centre trial (PANasta Trial).

2014 - 2016

Three-arm randomised trial of Arabin pessary, cervical cerclage and progesterone to prevent spontaneous preterm birth in an asymptomatic high risk cohort: a feasibility study.

2012 - 2015

Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol – (INFORM study).

2012 - 2015

Economic Evaluation of Plerixafor – (PHANTASTIC study).

2010 - 2014

The Impact of the Liverpool Care Pathway on care at the end of life. A comparison of two settings; Intensive care Units and Nursing Homes.


Evaluation of Advanced Life Support Training.

2010 - 2012

A PILOT Randomised control trial comparing two day and seven day antibiotic usage to treat HAI of unknown origin in ICU patients -READ-ICU TRIAL 

2010 - 2012

To develop and implement health needs assessment and predictive modelling using statistical and epidemiological methodologies.